VKTX Viking Therapeutics, Inc. - Common Stock
$34,83
Kurs · Aug 21, 2026
Fundamentaldaten per Jul 29, 2026
52W-Spanne
$23–$43
59% of range
Analystenbewertung
BUY
26 analysts
Kursziel
$92
+165% upside
P/E (TTM)
-10.9
ROE
-47.3%
Nettogewinnmarge
—
VKTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$34.83
Marktkapitalisierung
$4.00B
P/E (TTM)
-10.9
EPS (TTM)
$-3.19
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
-47.3%
Verschuldungsgrad
—
52W-Spanne
$23 – $43
VKTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2016-12-31
→
2025-12-31
EPS
$-3.19
2021-12-31
→
2025-12-31
Freier Cashflow
—
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
VKTX
Peer-Median
P/E (TTM)
-10.9
13.2
P/B (K/B)
6.3
3.5
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
VKTX
Peer-Median
ROA
-44.3%
-42.2%
ROE
-47.3%
-52.8%
ROIC
-61.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
VKTX
Peer-Median
Current Ratio (Liquiditätsgrad)
9.3
10.3
Quick Ratio
2.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
VKTX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
VKTX
Peer-Median
VKTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
26 Analysten
- Starker Kauf 9 34,6%
- Kauf 14 53,8%
- Halten 3 11,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
19 Analysten · 2026-08-19
Median
$95.00
← Unter allen Zielen
$34.83
Tief
$35.00
Hoch
$125.00
Median-Ziel
$95.00
+172,7%
Mittelwert-Ziel
$92.39
+165,3%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.16%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-1.10 | $-1.27 | 0.17% |
| 31. März 2026 | $-1.37 | $-1.03 | -0.34% |
| 31. Dezember 2025 | $-1.38 | $-0.91 | -0.47% |
| 30. September 2025 | $-0.81 | $-0.69 | -0.12% |
| 30. Juni 2025 | $-0.58 | $-0.46 | -0.12% |
| 31. März 2025 | $-0.41 | $-0.33 | -0.08% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | — |
| DNLI | $2.58B | -5.6 | 204.7% | — | -50.2% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
Bilanz 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
Cashflow 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | -223,856,000 | 112,320,000 | 112,134,000 | 112,069,000 | -215,721,000 | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | -223,856,000 | 112,320,000 | 112,134,000 | 112,069,000 | -215,721,000 | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
Bilanz 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-443M | $-360M | · | $-227M | $-158M | $-120M | · | $-97M | $-91M | $-89M | $-77M | $-72M | $-69M | $-63M | $-62M | $-59M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -10.1 | -10.3 | · | -13.0 | -18.8 | -22.2 | · | -69.6 | -60.2 | -88.2 | -12.6 | -18.4 | -18.5 | -3.3 | -3.6 | · | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -9.9% | -9.7% | · | -7.7% | -5.3% | -4.5% | · | -1.4% | -1.7% | -1.1% | -8.0% | -5.4% | -5.4% | -30.1% | -28.0% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $0 | $0 | $0 | $0 | $0 |
| Nettoergebnis | $-360M | $-110M | $-86M | $-69M | $-55M |
| Verwässerte EPS | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- 2 Beaten-Down Stocks With Massive Upside Potential
- Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
- Is Viking Therapeutics Stock Going to $100?
- Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
- 1 Grund, warum diese Biotech-Aktie bis zum Jahresende verdreifachen könnte.
- Got $1.500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
- Was man über diesen Entwickler von Medikamenten gegen Fettleibigkeit wissen sollte, der gerade eine neue Investition von 7 Millionen US-Dollar erhalten hat
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 503 Einreicher · $2.6B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 84 (+9 vs. Vorquartal) | 44 (-24 vs. Vorquartal) | 147 (-14 vs. Vorquartal) | 128 (+7 vs. Vorquartal) | +4.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| STATE STREET CORP | $218.705.430 | 5.606.394 | 8,30% | Aktien |
| FMR LLC | $197.202.455 | 5.055.177 | 7,49% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $197.143.394 | 5.053.663 | 7,48% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174.931.100 | 4.484.263 | 6,64% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $153.598.520 | 3.937.414 | 5,83% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113.382.565 | 2.906.500 | 4,30% | Kaufoption |
| TWO SIGMA ADVISERS, LP | $74.906.241 | 2.129.228 | 2,84% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $70.844.186 | 1.816.050 | 2,69% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $69.510.737 | 1.781.277 | 2,64% | Aktien |
| D. E. Shaw & Co., Inc. | $62.649.826 | 1.605.994 | 2,38% | Aktien |
| DIADEMA PARTNERS LP | $47.623.408 | 1.220.800 | 1,81% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46.039.602 | 1.180.200 | 1,75% | Verkaufsoption |
| CITADEL ADVISORS LLC | $43.773.121 | 1.122.100 | 1,66% | Kaufoption |
| BNP PARIBAS FINANCIAL MARKETS | $38.296.117 | 981.700 | 1,45% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31.846.477 | 816.367 | 1,21% | Aktien |
| GOLDMAN SACHS GROUP INC | $30.821.099 | 790.082 | 1,17% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $28.557.153 | 732.047 | 1,08% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28.504.217 | 730.690 | 1,08% | Aktien |
| Pictet Asset Management Holding SA | $26.640.280 | 682.909 | 1,01% | Aktien |
| Vestal Point Capital, LP | $26.526.800 | 680.000 | 1,01% | Aktien |
| AMERIPRISE FINANCIAL INC | $24.858.186 | 637.226 | 0,94% | Aktien |
| CITADEL ADVISORS LLC | $23.530.832 | 603.200 | 0,89% | Verkaufsoption |
| Eversept Partners, LP | $23.519.987 | 602.922 | 0,89% | Aktien |
| BlackBarn Capital Partners LP | $23.406.000 | 600.000 | 0,89% | Aktien |
| JANE STREET GROUP, LLC | $22.996.200 | 589.495 | 0,87% | Aktien |
| ADAR1 Capital Management, LLC | $22.393.222 | 574.038 | 0,85% | Aktien |
| JANE STREET GROUP, LLC | $20.870.350 | 535.000 | 0,79% | Kaufoption |
| DIMENSIONAL FUND ADVISORS LP | $20.787.961 | 532.888 | 0,79% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $20.698.979 | 530.607 | 0,79% | Aktien |
| Caption Management, LLC | $20.511.458 | 525.800 | 0,78% | Kaufoption |
| TANG CAPITAL MANAGEMENT LLC | $19.505.000 | 500.000 | 0,74% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $19.433.690 | 498.172 | 0,74% | Aktien |
| Point72 Asset Management, L.P. | $18.463.745 | 473.308 | 0,70% | Aktien |
| Clearbridge Investments, LLC | $17.350.907 | 444.781 | 0,66% | Aktien |
| DIADEMA PARTNERS LP | $17.234.930 | 441.808 | 0,65% | Aktien |
| BLAIR WILLIAM & CO/IL | $16.258.035 | 416.766 | 0,62% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $15.513.614 | 397.683 | 0,59% | Aktien |
| BlackRock, Inc. | $15.432.395 | 395.601 | 0,59% | Aktien |
| ExodusPoint Capital Management, LP | $15.346.650 | 393.000 | 0,58% | Kaufoption |
| Walleye Trading LLC | $14.964.236 | 383.600 | 0,57% | Kaufoption |
| First Washington CORP | $14.874.513 | 381.300 | 0,56% | Aktien |
| ExodusPoint Capital Management, LP | $14.087.525 | 361.126 | 0,53% | Aktien |
| Steward Partners Investment Advisory, LLC | $13.699.454 | 351.178 | 0,52% | Aktien |
| DIADEMA PARTNERS LP | $13.673.005 | 350.500 | 0,52% | Verkaufsoption |
| JANE STREET GROUP, LLC | $12.955.221 | 332.100 | 0,49% | Verkaufsoption |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $12.877.000 | 330.100 | 0,49% | Aktien |
| Woodline Partners LP | $11.810.317 | 302.751 | 0,45% | Aktien |
| GROUP ONE TRADING LLC | $10.198.891 | 261.443 | 0,39% | Aktien |
| WASATCH ADVISORS LP | $10.190.161 | 313.158 | 0,39% | Aktien |
| PFM Health Sciences, LP | $9.960.423 | 255.330 | 0,38% | Aktien |
| BlackBarn Capital Partners LP | $9.752.500 | 250.000 | 0,37% | Kaufoption |
| Gotham Asset Management, LLC | $9.001.050 | 230.737 | 0,34% | Aktien |
| BANK OF AMERICA CORP /DE/ | $8.875.595 | 227.521 | 0,34% | Aktien |
| Swiss National Bank | $8.617.309 | 220.900 | 0,33% | Aktien |
| Nuveen Asset Management, LLC | $8.168.680 | 202.999 | 0,31% | Aktien |
| ACT CAPITAL MANAGEMENT, LLC | $8.164.793 | 209.300 | 0,31% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.833.596 | 200.810 | 0,30% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $7.697.882 | 197.331 | 0,29% | Aktien |
| Cetera Investment Advisers | $7.199.003 | 184.543 | 0,27% | Aktien |
| WOLVERINE TRADING, LLC | $7.128.722 | 276.200 | 0,27% | Kaufoption |
| Artia Global Partners LP | $7.050.316 | 180.731 | 0,27% | Aktien |
| LPL Financial LLC | $6.377.862 | 163.493 | 0,24% | Aktien |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $6.072.375 | 155.662 | 0,23% | Aktien |
| Granahan Investment Management, LLC | $5.775.196 | 148.044 | 0,22% | Aktien |
| OPPENHEIMER & CO INC | $5.705.564 | 146.259 | 0,22% | Aktien |
| RFG Advisory, LLC | $5.570.234 | 142.790 | 0,21% | Aktien |
| UBS Group AG | $5.212.672 | 133.624 | 0,20% | Aktien |
| Rhenman & Partners Asset Management AB | $4.993.280 | 128.000 | 0,19% | Aktien |
| Balyasny Asset Management L.P. | $4.521.493 | 115.906 | 0,17% | Aktien |
| RHUMBLINE ADVISERS | $4.455.330 | 114.211 | 0,17% | Aktien |
| FIRST TRUST ADVISORS LP | $4.437.402 | 113.751 | 0,17% | Aktien |
| Persistent Asset Partners Ltd | $4.397.831 | 112.736 | 0,17% | Aktien |
| Trexquant Investment LP | $4.388.586 | 112.499 | 0,17% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $4.273.936 | 109.560 | 0,16% | Aktien |
| Institute for Wealth Management, LLC. | $4.238.164 | 108.643 | 0,16% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.049.668 | 124.452 | 0,15% | Aktien |
| Caption Management, LLC | $4.006.327 | 102.700 | 0,15% | Verkaufsoption |
| Rafferty Asset Management, LLC | $3.880.520 | 99.475 | 0,15% | Aktien |
| Quantum Private Wealth, LLC | $3.837.238 | 98.365 | 0,15% | Aktien |
| Man Group plc | $3.718.979 | 95.334 | 0,14% | Aktien |
| LBP AM SA | $3.663.273 | 93.906 | 0,14% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $3.642.910 | 93.384 | 0,14% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $3.574.642 | 91.634 | 0,14% | Aktien |
| AXQ CAPITAL, LP | $3.566.957 | 91.437 | 0,14% | Aktien |
| WINTON GROUP Ltd | $3.532.199 | 90.546 | 0,13% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $3.510.900 | 90.000 | 0,13% | Kaufoption |
| Bridgewater Associates, LP | $3.427.380 | 87.859 | 0,13% | Aktien |
| VANGUARD GROUP INC | $3.364.967 | 95.650 | 0,13% | Aktien |
| Cornerstone Capital, Inc. | $3.334.185 | 85.470 | 0,13% | Aktien |
| EXCHANGE TRADED CONCEPTS, LLC | $3.167.066 | 81.186 | 0,12% | Aktien |
| 683 Capital Management, LLC | $3.120.800 | 80.000 | 0,12% | Kaufoption |
| CAPITAL FUND MANAGEMENT S.A. | $2.934.176 | 75.216 | 0,11% | Aktien |
| Odyssean, LLC | $2.925.243 | 74.987 | 0,11% | Aktien |
| D. E. Shaw & Co., Inc. | $2.921.849 | 74.900 | 0,11% | Kaufoption |
| Y-Intercept (Hong Kong) Ltd | $2.825.884 | 72.440 | 0,11% | Aktien |
| WOLVERINE TRADING, LLC | $2.813.290 | 109.000 | 0,11% | Verkaufsoption |
| Lewis Asset Management, LLC | $2.605.478 | 66.790 | 0,10% | Aktien |
| Summit Financial, LLC | $2.605.301 | 66.785 | 0,10% | Aktien |
| CITADEL ADVISORS LLC | $2.599.743 | 66.643 | 0,10% | Aktien |
| MONIMUS CAPITAL MANAGEMENT, LP | $2.594.243 | 66.502 | 0,10% | Aktien |
Unternehmensinsider 16 Insider · 9 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | 29. Juli 2026 S | 2.572.441 | 0 | 6 | $-14.005.897 |
| Greg Zante | Chief Financial Officer | 29. Juli 2026 S | 212.204 | 0 | 6 | $-2.823.737 |
| Marianna Mancini | Chief Operating Officer | 29. Juli 2026 S | 422.760 | 0 | 6 | $-2.727.473 |
| Michael Dinerman | Chief Operating Officer | 4. Mai 2015 C | 694.116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | 1. Juni 2026 A | — | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | 10. März 2026 P | 4.475 | 1 | 0 | $149.912 |
| Michael Morneau | VP, Finance and Administration | 19. Januar 2021 F | 116.062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | 3. Januar 2019 A | 141.063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | 4. Mai 2016 F | 160.836 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | Direktor | 2. Januar 2026 A | 4.390 | 0 | 0 | $0 |
| Lawson Macartney | Direktor | 2. Januar 2026 A | 51.115 | 0 | 0 | $0 |
| Charles A Rowland Jr | Direktor | 2. Januar 2026 A | 33.150 | 0 | 1 | $-2.134.200 |
| Matthew J Singleton | Direktor | 2. Januar 2026 A | 12.650 | 0 | 0 | $0 |
| Matthew W Foehr | Direktor | 2. Januar 2026 A | 135.186 | 0 | 1 | $-561.760 |
| Stephen W Webster | Direktor | 2. Januar 2020 A | 8.000 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | — | 1. August 2026 A | 6.333 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 58 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 2,41% | 119.108 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,82% | 135.757 NS | 30. April 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 0,75% | 22.931 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,62% | 7.443 NS | 30. April 2026 | N-PORT |
| HRTS · Tema ETF Trust | 0,54% | 8.538 NS | 31. Mai 2026 | N-PORT |
| EVNT · AltShares Trust | 0,53% | 2.000 NS | 31. Mai 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,43% | 5.422 NS | 31. Mai 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,39% | 109.034 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 2.593 NS | 30. April 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,19% | 1.854 NS | 31. Mai 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,15% | 3.856 NS | 30. April 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,12% | 1.464.336 SH | 19. August 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 24.522 SH | 20. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,08% | 555.687 NS | 31. Mai 2026 | N-PORT |
| ISCV · iShares Trust | 0,07% | 12.964 SH | 20. August 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 42.871 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,06% | 65.910 SH | 20. August 2026 | Täglich |
| ISCB · iShares Trust | 0,06% | 4.916 SH | 20. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,06% | 330.703 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 48.084 SH | 20. August 2026 | Täglich |
| ISCG · iShares Trust | 0,06% | 15.800 SH | 20. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 49.795 NS | 30. April 2026 | N-PORT |
| SMMD · iShares Trust | 0,05% | 57.256 SH | 20. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 1.332.828 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,05% | 2.530.231 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 30.667 SH | 20. August 2026 | Täglich |
| IWS · iShares Trust | 0,04% | 157.706 SH | 20. August 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 6.482 SH | 20. August 2026 | Täglich |
| IWR · iShares Trust | 0,03% | 460.084 SH | 20. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 4.353 NS | 31. Mai 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,02% | 56 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 48.308 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 35.206 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3.501.108 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 19.254 SH | 19. August 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 63.630 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.458 SH | 19. August 2026 | Täglich |
| IWD · iShares Trust | 0,01% | 234.135 SH | 20. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 25.563 SH | 19. August 2026 | Täglich |
| GVUS · Goldman Sachs ETF Trust | 0,01% | 1.208 NS | 31. Mai 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,01% | 791 NS | 30. April 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 47.795 SH | 20. August 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 159.205 SH | 20. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 3.542 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 71.527 NS | 31. Mai 2026 | N-PORT |
| IWB · iShares Trust | 0,01% | 72.826 SH | 20. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 27.921 SH | 20. August 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,00% | 8.429 NS | 30. April 2026 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4.089 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9.871 NS | 30. April 2026 | N-PORT |